Skip to main content

Table 3 Rate of Incident TB in entire cohort and subgroup analysis

From: Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India

Characteristics

Entire Cohort

(n = 1904)

Patients with NO baseline prevalent TB

(n = 1267)

Number of patients (n)

Incidence rate (95% CI)per 100 person years

Number of patients (n)

Incidence rate (95% CI)

per 100 person years

Total patients

182

1.85 (1.604, 2.144)

113

1.73 (1.436, 2.076)

Age (years)

  ≤ 40 years

100

1.83 (1.502, 2.223)

63

1.75 (1.363, 2.233)

  > 40 years

82

1.89 (1.521, 2.344)

50

1.71 (1.292, 2.249)

Gender

 Female

50

1.49 (1.132, 1.971)

35

1.34 (0.961, 1.865)

 Male

132

2.04 (1.721, 2.421)

78

1.98 (1.589, 2.478)

History of prior TB at baseline

 Yes

69

2.11 (1.666, 2.671)

  

 No

113

1.73 (1.436, 2.076)

  

Haemoglobin at baseline (g/dl)

(n = 156)

 

(n = 88)

 

  ≤ 10

53

2.84 (2.171, 3.719)

65

2.79 (1.853, 4.196)

  > 10

103

1.58 (1.304, 1.919)

23

1.43 (1.125, 1.830)

Virologic status on ART

 Virologic failure (VF)

105

8.51 (7.030, 10.307)

71

10.23 (8.107, 12.910)

 Virologic suppression (VS)

77

0.90 (0.717, 1.122)

42

0.72 (0.530, 0.972)

IPT

 ART plus IPT

5

0.20 (0.081, 0.469)

2

0.11 (0.026, 0.423)

 ART alone

177

2.44 (2.106, 2.828)

111

2.38 (1.979, 2.872)

Duration of ART (months)

  ≤ 12

33

24.32 (17.293, 34.215)

23

25.58 (16.998, 38.492)

 13–36

52

5.46 (4.162, 7.167)

29

4.32 (3.005, 6.223)

 37–60

44

2.54 (1.890, 3.413)

28

2.41 (1.666, 3.495)

  > 60

53

0.75 (0.579, 0.992)

33

0.72 (0.507, 1.004)

Pre ART CD4 count (cells/mm3)

  ≤ 50

32

2.28 (1.612, 3.224)

18

2.57 (1.621, 4.085)

 51–200

108

2.20 (1.824, 2.660)

59

1.98 (1.537, 2.560)

 201–500

41

1.28 (0.943, 1.740)

35

1.35 (0.967, 1.875)

  >  500

1

0.32 (0.045, 2.303)

1

0.36 (0.052, 2.625)

Current/ updated CD4 count (cells/mm3)

  ≤ 200

107

7.36 (6.090, 8.896)

65

8.35 (6.548, 10.648)

 201–350

36

1.75 (1.265, 2.432)

22

1.64 (1.078, 2.486)

 351–500

20

1.03 (0.667, 1.602)

12

0.97 (0.552, 1.711)

  >  500

19

0.43 (0.277, 0.681)

14

0.44 (0.260, 0.741)

  1. ART antiretroviral therapy, IPT Isoniazid preventive therapy, TB tuberculosis